To target glioma both in vitro and in vivo, sHDL nanodiscs were loaded with CpG deoxynucleotides, a Toll-like receptor 9 (TLR9) agonist, and a chemotherapeutic, namely docetaxel (DTX). The gene discussed is TLR9; the disease is central nervous system cancer.